Stanley Appel

Company: Houston Methodist Neurological Institute; Advisory Board Chair COYA Therapeutics

Job title: Co-Director

Seminars:

Suppressing Neuroinflammation: T-REG Cell Therapy of ALS 5:00 pm

Analyzing T-regs dysfunctional in neurodegenerative diseases to aid future therapeutic development Understanding how ex vivo expansion restores T-Reg suppressive function to highlight neuroprotective factors that may arise from targeting neuroinflammation Using clinical trial data to highlight how autologous T-reg infusions slow disease progression to thus suggest a potential avenue towards curing neurodegenerative diseasesRead more

day: Day One

Opening Panel Discussion: What’s New in Neuroimmunology Drug Development? 9:00 am

What are the new biomarkers and targets within neuroimmunology? Innovation in neuropsychiatric drug development Updates on the role of cells beyond microglia in neuroinflammationRead more

day: Day One